Edwards Lifesciences Corp. Stock Advances 4.1%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Edwards Lifesciences Corp. advanced 4.1% to $89.28 on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.4% to 7,551.81 and Dow Jones Industrial Average falling 1.2% to 51,461.90.

This was the stock's third consecutive day of gains.

Edwards Lifesciences Corp. closed 7.3% short of its 52-week high of $96.29, which the company reached on July 7th.

The stock outperformed some of its peers, as Abbott Laboratories rose 0.3% to $102.36, Medtronic PLC fell 1.2% to $92.60, and Stryker Corp. rose 1.16% to $284.76.

Trading volume totaled 4.9 million, compared to the 50-day average of 3.9 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 16, 2026 16:35 ET (20:35 GMT)